Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
暂无分享,去创建一个
Bénédicte Lebrun-Vignes | Joe-Elie Salem | J. Sosman | Douglas B. Johnson | J. Moslehi | J. Salem | Jeffrey A Sosman | Douglas B Johnson | B. Lebrun-Vignes | Javid J Moslehi
[1] J. Grob,et al. Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity. , 2017, Circulation.
[2] J. Seidman,et al. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. , 2016, The New England journal of medicine.
[3] Hussein Tawbi,et al. Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy , 2016, Journal of Immunotherapy for Cancer.
[4] J. Wolchok. PD-1 Blockers , 2015, Cell.
[5] M. Lindquist. VigiBase, the WHO Global ICSR Database System: Basic Facts , 2008 .